Almost every biotech has a Scientific Advisory Board, but few use them particularly well. Although SABs can be hugely valuable in helping shape a program or portfolio, or raising the visibility of a startup, they can also be a colossal distraction and huge time sink, burning resources and creating post-meeting firedrills. To help the startup entrepreneur think through their SAB, I’ve polled a few of our portfolio exec’s* about what works, and combined it with my own experiences. This post is...